Brind.

Entities / Person

Lars Fruergaard Jørgensen.

former CEO of Novo Nordisk

Seen in 9 reportsLast reported Oct 18

Reports this week: 0
Active events: 1
Connections: 2

What's happening

Reports per dayLast 90 days

90 days agoDrag either end to show only events that began in that periodToday

Active this week

Personnel changes at Novo Nordisk and Lundbeck, including Mike Doustdar succeeding Lars Fruergaard Jørgensen and proposals for Lundbeck's board.

Some support2 reports

Around Lars Fruergaard Jørgensen this week

News at the entities that move Lars Fruergaard Jørgensen most

Novo Nordisk Structural
Novo Nordisk and Astellas Pharma are noted as large-cap healthcare companies, with Novo Nordisk reporting higher revenue and earnings.

Moves Lars Fruergaard Jørgensen
Fri 18:20

Connections

Strongest first. The bars show how strongly a change on one side reaches the other.

Novo Nordisk Structural

Lars Fruergaard Jørgensen serves as the CEO and leader of Novo Nordisk, with his tenure tied to the company's market performance and clinical advancements.

Some supportOct 18

Lars Fruergaard Jørgensen → Novo Nordisk
Novo Nordisk → Lars Fruergaard Jørgensen
Lundbeck Structural

Lars Fruergaard Jørgensen is proposed to chair the board of Lundbeck.

Some supportOct 18

Lars Fruergaard Jørgensen → Lundbeck
Lundbeck → Lars Fruergaard Jørgensen

History

Events by the month they began

October 2026

1 event

Oct 18, 2026Personnel changes at Novo Nordisk and Lundbeck, including Mike Doustdar succeeding Lars Fruergaard Jørgensen and proposals for Lundbeck's board.